Altered angiogenesis gene expression in gastrointestinal stromal tumors: Potential use in diagnosis, outcome prediction, and treatment

Neoplasma

Volumn 59, Issue 4, 2012, Pages 384-392

  Zhao, Yi ^a   Wang, Q ^a   Deng, X ^a   Zhao, Y ^a  

^a Shengjing Hospital Affiliated to China Medical University   (China)

Author keywords

Angiogenesis; Disease free survival; Endothelial growth factor (VEGF); Gastrointestinal stromal tumors (GISTs); Microvascular density (MVD); PI3K AKt signaling pathway

Indexed keywords

CD34 ANTIGEN; DESMIN; PROTEIN S 100; SMAD PROTEIN; STEM CELL FACTOR RECEPTOR; ANGIOGENIC PROTEIN; MESSENGER RNA; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CANCER STAGING; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GASTROINTESTINAL TRACT; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; ANGIOGENIC PROTEINS; BLOTTING, WESTERN; CHILD; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; GASTROINTESTINAL TRACT; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84864531827     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_050     Document Type: Article

References (26)

1. LAURINI JA, CARTER JE. Gastrointestinal stromal tumors. Arch. Pathol. Lab. Med. 2010; 134: 134-141.
2. NGUYEN SQ, DIVINO CM, WANG JL, DIKMAN SH. Laparoscopic management of gastrointestinal stromal tumors. Surg. Endosc. 2006; 20: 713-716. http://dx.doi.org/10.1007/s00464-005-0435-8
3. AN JY, CHOI MG, NOH JH, SOHN TS, KANG WK, et al. Gastric GIST: A single institutional retrospective experience with surgical treatment for primary disease. EJSO. 2007; 33: 1030-1035. http://dx.doi.org/10.1016/j.ejso.2007.02.009
4. EDLING CE, HALLBERG B. c-Kit--a hematopoietic cell essential receptor tyrosine kinase. Int. J. Biochem. Cell Biol. 2007; 39: 1995-1998. http://dx.doi.org/10.1016/j.biocel.2006.12.005
5. BAUER S, DUENSING A, DEMETRI GD, FLETCHER JA. KIT oncogenic signaling mechanisms in imatinab-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a cucial survival pathway. Oncogene. 2007; 26: 7560-7568. http://dx.doi.org/10.1038/sj.onc.1210558
6. YUAN TL, CANTLEY LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008; 27: 5497-5510. http://dx.doi.org/10.1038/onc.2008.245
7. CARNERO A, BLANCO-APARICIO C, RENNER O, LINK W, LEAL JF et al. The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications. Curr. Cancer Drug Targets 2008; 8: 187-198. http://dx.doi.org/10.2174/156800908784293659
8. CARRACEDO A, PANDOLFI PP. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008; 27: 5527-5541. http://dx.doi.org/10.1038/onc.2008.247
9. KESSENBROCK K, PLAKS V, WERB Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67. http://dx.doi.org/10.1016/j.cell.2010.03.015
10. CARNERO A, BLANCO-APARICIO C, RENNER O, LINK W, LEAL JF et al. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 2008; 8: 187-198. http://dx.doi.org/10.2174/156800908784293659
11. MORBIDELLI L, DONNINI S, ZICHE M. Role of nitric oxide in tumor angiogenesis. Cancer Treat Res. 2004; 117: 155-167. http://dx.doi.org/10.1007/978-1-4419-8871-3_11
12. BALUK P, HASHIZUME H, MCDONALD DM. Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 2005; 15: 102-111. http://dx.doi.org/10.1016/j.gde.2004.12.005
13. BALUK P, HASHIZUME H, MCDONALD DM. Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 2005; 15: 102-111. http://dx.doi.org/10.1016/j.gde.2004.12.005
14. FLETCHER CD, BERMAN JJ, CORLESS C, GORSTEIN F, LASOTA J et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int. J. Surg. Pathol. 2002; 10: 81-89. http://dx.doi.org/10.1177/106689690201000201
15. WEIDNER N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin. Diagn. Pathol. 1993; 10: 302-313.
16. CRISTINA R. ANTONESCU. Targeted therapies in gastrointestinal stromal tumors. Semin. Diagn. Pathol. 2008; 25: 295-303. http://dx.doi.org/10.1053/j.semdp.2008.08.004
17. YANG J, DU X, LAZAR AJ, POLLOCK R, HUNT K et al. Genetic aberrations of gastrointestinal stromal tumors. Cancer 2008; 113: 1532-1543. http://dx.doi.org/10.1002/cncr.23778
18. WAITE KA, ENG C. Protean PTEN: form and function. Am. J. Hum. Genet. 2002; 70: 829-844. http://dx.doi.org/10.1086/340026
19. BEL AIBA RS, DIMOVA EY, GORLACH A, KIETZMANN T. The role of hypoxia inducible factor-1 in cell metabolism--a possible target in cancer therapy. Expert Opin. Ther. Targets 2006; 10: 583-599. http://dx.doi.org/10.1517/14728222.10.4.583
20. RADISAVLJEVIC Z. AKT as locus of fragility in robust cancer system. J. Cell Biochem. 2008; 104: 2071-2077. http://dx.doi.org/10.1002/jcb.21777
21. BERTA M, BRAHIMI-HORN C, Pouyssegur J. Regulation of the Hypoxia-Inducible Factor-1alpha (HIF-1alpha): a breath of fresh air in hypoxia research. J. Soc. Biol. 2004; 198: 113-120.
22. TAKAHASHI R, TANAKA S, KITADAI Y, SUMII M, YOSHIHARA M et al. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 2003; 64: 266-274. http://dx.doi.org/10.1159/000069316
23. LI L, WANG L, ZHANG W, TANG B, ZHANG J et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer. Res. 2004; 24: 1973-1979.
24. SARTELET H, OLIGNY LL, VASSAL G. AKT pathway in neuroblastoma and its therapeutic mplication. Expert Rev. Anticancer. Ther. 2008; 8: 757-769. http://dx.doi.org/10.1586/14737140.8.5.757
25. FITZPATRICK B, MEHIBEL M, COWEN RL, STRATFORD IJ. iNOS as a therapeutic target for treatment of human tumors. Nitric. Oxide. 2008; 19: 217-224. http://dx.doi.org/10.1016/j.niox.2008.05.001
26. JOHN A, TUSZYNSKI G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 2001; 7: 14-23. http://dx.doi.org/10.1007/BF03032599